Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:766-772
Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000154364.00763.d5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/4/766    most recent
01.HYP.0000154364.00763.d5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grim, C. E.
Right arrow Articles by Kotchen, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grim, C. E.
Right arrow Articles by Kotchen, T. A.
Related Collections
Right arrow Clinical Studies
Right arrow Other hypertension

(Hypertension. 2005;45:766.)
© 2005 American Heart Association, Inc.


Original Articles

Hyperaldosteronism and Hypertension

Ethnic Differences

Clarence E. Grim; Allen W. Cowley, Jr; Pavel Hamet; Daniel Gaudet; Mary L. Kaldunski; Jane Morley Kotchen; Shanthi Krishnaswami; Zdenka Pausova; Richard Roman; Johanne Tremblay; Theodore A. Kotchen

From the Departments of Medicine (C.E.G., S.K., T.A.K.), Physiology (A.W.C., M.L.K., R.R.), and Epidemiology (J.M.K.), Medical College of Wisconsin, Milwaukee; and Centre Hospitalier (P.H., D.G., Z.P., J.T.), University of Montreal, Canada.

Correspondence to Theodore A. Kotchen, MD, Professor of Medicine, Associate Dean for Clinical Research, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226. E-mail tkotchen{at}mcw.edu

The purpose of this study is to evaluate the relationship between aldosterone and blood pressure in a total of 220 normotensive and 293 essential hypertensive subjects in 2 genetically distinct populations—blacks and white French Canadians. The 24-hour blood pressure monitoring was performed under standardized conditions after discontinuing antihypertensive medications. Plasma renin activity and plasma aldosterone were measured in the supine position and after standing for 10 minutes. Plasma atrial natriuretic factor was also measured. Supine and standing plasma renin activities were lower (P≤0.01), plasma aldosterone was higher (P<0.0001), and the aldosterone/renin ratios were higher (P<0.0001) in the hypertensive subjects. Atrial natriuretic factor was also higher in the hypertensive subjects (P<0.0001). Among blacks, blood pressures did not correlate with plasma renin activity. However, both average daytime and nighttime systolic and diastolic blood pressures were correlated with supine and standing plasma aldosterone and with the aldosterone/renin ratio (P<0.005 or less). In French Canadians, blood pressures tended to be positively correlated with standing plasma renin activity and aldosterone, but not with the aldosterone/renin ratio. Correlations of blood pressure with aldosterone were more consistent and more striking in blacks than in French Canadians. In both ethnic groups, there were inconsistent correlations of blood pressure with atrial natriuretic factor. These observations are consistent with the hypothesis that aldosterone-induced volume expansion is an important contributor to hypertension, especially in blacks.


Key Words: aldosterone • blacks • blood pressure • hypertension • renin




This article has been cited by other articles:


Home page
HypertensionHome page
A. W. Krug and M. Ehrhart-Bornstein
Aldosterone and Metabolic Syndrome: Is Increased Aldosterone in Metabolic Syndrome Patients an Additional Risk Factor?
Hypertension, May 1, 2008; 51(5): 1252 - 1258.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi
Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients
Diabetes Care, September 1, 2007; 30(9): 2349 - 2354.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. M. Jones, T. C. Dowling, J.-J. Park, D. A. Phares, J.-Y. Park, T. O. Obisesan, and M. D. Brown
Human, Environmental & Exercise: Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians
Exp Physiol, September 1, 2007; 92(5): 871 - 879.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. E. Umpierrez, P. Cantey, D. Smiley, A. Palacio, D. Temponi, K. Luster, and A. Chapman
Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
Diabetes Care, July 1, 2007; 30(7): 1699 - 1703.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Kidambi, J. M. Kotchen, C. E. Grim, H. Raff, J. Mao, R. J. Singh, and T. A. Kotchen
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Hypertension, March 1, 2007; 49(3): 704 - 711.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Calhoun
Aldosterone and Cardiovascular Disease: Smoke and Fire
Circulation, December 12, 2006; 114(24): 2572 - 2574.
[Full Text] [PDF]


Home page
CJASNHome page
D. A. Calhoun
Aldosteronism and Hypertension
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1039 - 1045.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Bochud, J. Nussberger, P. Bovet, M. R. Maillard, R. C. Elston, F. Paccaud, C. Shamlaye, and M. Burnier
Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome
Hypertension, August 1, 2006; 48(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Spence
Letter to the Editor: Individualized Therapy for Hypertension
Hypertension, March 1, 2006; 47(3): e11 - e11.
[Full Text] [PDF]